This article is more than 5 years old. Information may no longer be current.

Lumenis revenues drop in third quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

YOKNEAM, Israel — Lumenis reported revenues for its third quarter of $62.5 million, down from $66.2 million in the third quarter of 2003, according to a press release from the company. Gross profit improved to $30.3 million from $26.6 million in the third quarter of 2003, the press release said.

Sales in the Americas region were $30.7 million; in Europe, $11.8 million; and in the Asia-Pacific region, $20.1 million, the company announced. Its ophthalmic product line accounted for $13.2 million in sales, down from the $16.6 million in the third quarter of 2003. Net loss for the quarter totaled $2.3 million and reflected the company’s new sales and marketing agreement with WaveLight Laser Technologie, according to Lumenis.

Avner Raz, president and chief executive officer of Lumenis, said in the press release that the company now has a growing backlog of orders, and a high-powered 532-nm photocoagulator laser was debuted at last month’s American Academy of Ophthalmology meeting.